M1 RNA is important for the in-cell solubility of its cognate C5 protein: Implications for RNA-mediated protein folding

RNA Biology

Volumn 12, Issue 11, 2015, Pages 1198-1208

  Son, Ahyun ^a   Choi, Seong Il ^a   Han, Gyoonhee ^a   Seong, Baik L ^a  

^a Yonsei University   (South Korea)

Author keywords

Aggregation; C5 protein; M1 RNA; Protein folding; RNA mediated chaperoning function; RNase P

Indexed keywords

BACTERIAL ENZYME; BACTERIAL PROTEIN; BACTERIAL RNA; PROTEIN C5; RIBONUCLEASE P; RIBOZYME; RNA M1; UNCLASSIFIED DRUG; ESCHERICHIA COLI PROTEIN; INTRINSICALLY DISORDERED PROTEIN; PROTEIN BINDING; RECOMBINANT PROTEIN; RIBONUCLEASE P, E COLI;

ARTICLE; BACTERIAL CELL; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; PROTEIN REFOLDING; PROTEIN RNA BINDING; PROTEIN SUBUNIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; AMINO ACID SEQUENCE; BIOLOGICAL MODEL; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; PROTEIN DOMAIN; PROTEIN STABILITY; SEQUENCE ALIGNMENT; SOLUBILITY;

AMINO ACID SEQUENCE; ESCHERICHIA COLI PROTEINS; INTRINSICALLY DISORDERED PROTEINS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN REFOLDING; PROTEIN STABILITY; RECOMBINANT PROTEINS; RIBONUCLEASE P; RNA, BACTERIAL; SEQUENCE ALIGNMENT; SOLUBILITY;

EID: 84964056001     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.1080/15476286.2015.1096487     Document Type: Article

References (74)

1. Robertson HD, Altman S, Smith JD. Purification and properties of a specific Escherichia coli ribonuclease which cleaves a tyrosine transfer ribonucleic acid presursor. J Biol Chem 1972; 247:5243-51; PMID:4560501
2. Walker SC, Engelke DR. Ribonuclease P: the evolution of an ancient RNA enzyme. Crit Rev Biochem Mol Biol 2006; 41:77-102; PMID:16595295; http://dx.doi.org/10.1080/10409230600602634
3. Vioque A, Arnez J, Altman S. Protein-RNA interactions in the RNase P holoenzyme from Escherichia coli. J Mol Biol 1988; 202:835-48; PMID:2459398; http://dx.doi.org/10.1016/0022-2836(88)90562-1
4. Frank DN, Pace NR. Ribonuclease P: Unity and diversity in a tRNA processing ribozyme. Annu Rev Biochem 1998; 67:153-80; PMID:9759486; http://dx.doi.org/10.1146/annurev.biochem.67.1.153
5. Srisawat C, Houser-Scott F, Bertrand E, Xiao SH, Singer RH, Engelke DR. An active precursor in assembly of yeast nuclear ribonuclease P. RNA 2002; 8:1348-60; PMID:12403471; http://dx.doi.org/10.1017/S1355838202027048
6. Bukau B, Horwich AL. The Hsp70 and Hsp60 chaperone machines. Cell 1998; 92:351-66; PMID:9476895; http://dx.doi.org/10.1016/S0092-8674(00)80928-9
7. Hartl FU, Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 2002; 295:1852-8; PMID:11884745; http://dx.doi.org/10.1126/science.1068408
8. Steitz TA. From the structure and function of the ribosome to new antibiotics (Nobel Lecture). Angew Chem Int Ed Engl 2010; 49:4381-98; PMID:20509130; http://dx.doi.org/10.1002/anie.201000708
9. Harms J, Schluenzen F, Zarivach R, Bashan A, Gat S, Agmon I, Bartels H, Franceschi F, Yonath A. High resolution structure of the large ribosomal subunit from a mesophilic Eubacterium. Cell 2001; 107:679-88; PMID:11733066; http://dx.doi.org/10.1016/S0092-8674(01)00546-3
10. Wimberly BT, Brodersen DE, Clemons WM, Morgan-Warren RJ, Carter AP, Vonrhein C, Hartsch T, Ramakrishnan V. Structure of the 30S ribosomal subunit. Nature 2000; 407:327-39; PMID:11014182; http://dx.doi.org/10.1038/35030006
11. Cate JH, Yusupov MM, Yusupova GZ, Earnest TN, Noller HF. X-ray crystal structures of 70S ribosome functional complexes. Science 1999; 285:2095-104; PMID:10497122; http://dx.doi.org/10.1126/science.285.5436.2095
12. Belzil VV, Gendron TF, Petrucelli L. RNA-mediated toxicity in neurodegenerative disease. Mol Cell Neurosci 2012; 56:406-19; PMID:23280309
13. Prusiner SB. Shattuck lecture-Neurodegenerative diseases and prions. New Engl J Med 2001; 344:1516-26; PMID:11357156; http://dx.doi.org/10.1056/NEJM200105173442006
14. Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1993; 90:11282-6; PMID:8248242; http://dx.doi.org/10.1073/pnas.90.23.11282
15. Glenner GG, Wong CW, Quaranta V, Eanes ED. The amyloid deposits in Alzheimer’s disease: their nature and pathogenesis. Appl Pathol 1984; 2:357-69; PMID:6242724
16. Zoghbi HY, Orr HT. Polyglutamine diseases: protein cleavage and aggregation. Curr Opin Neurobiol 1999; 9:566-70; PMID:10508741; http://dx.doi.org/10.1016/S0959-4388(99)00013-6
17. Uversky VN. Intrinsic disorder in proteins associated with neurodegenerative diseases. Front Biosci 2009; 14:5188-238; http://dx.doi.org/10.2741/3594
18. Uversky VN, Narizhneva NV. Effect of natural ligands on the structural properties and conformational stability of proteins. Biochemistry (Mosc) 1998; 63:420-33; PMID:9556525
19. Dunker AK, Lawson JD, Brown CJ, Williams RM, Romero P, Oh JS, Oldfield CJ, Campen AM, Ratliff CM, Hipps KW, et al. Intrinsically disordered protein. J Mol Graph Model 2001; 19:26-59; PMID:11381529; http://dx.doi.org/10.1016/S1093-3263(00)00138-8
20. Uversky VN, Gillespie JR, Fink AL. Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins 2000; 41:415-27; PMID:11025552; http://dx.doi.org/10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.0. CO;2-7
21. Wright PE, Dyson HJ. Intrinsically unstructured proteins: Re-assessing the protein structure-function paradigm. J Mol Biol 1999; 293:321-31; PMID:10550212; http://dx.doi.org/10.1006/jmbi.1999.3110
22. Plaxco KW, Gross M. Cell biology-The importance of being unfolded. Nature 1997; 386:657-9; PMID:9109481; http://dx.doi.org/10.1038/386657a0
23. Das B, Chattopadhyay S, Bera AK, Dasgupta C. In vitro protein folding by ribosomes from Escherichia coli, wheat germ and rat liver: the role of the 50S particle and its 23S rRNA. Eur J Biochem 1996; 235:613-21; PMID:8654409; http://dx.doi.org/10.1111/j.1432-1033.1996.00613.x
24. Chattopadhyay S, Das B, Dasgupta C. Reactivation of denatured proteins by 23S ribosomal RNA: role of domain V. Proc Natl Acad Sci USA 1996; 93:8284-7; PMID:8710862; http://dx.doi.org/10.1073/pnas.93.16.8284
25. Kudlicki W, Coffman A, Kramer G, Hardesty B. Ribosomes and ribosomal RNA as chaperones for folding of proteins. Fold Des 1997; 2:101-8; PMID:9135982; http://dx.doi.org/10.1016/S1359-0278(97)00014-X
26. Samanta D, Mukhopadhyay D, Chowdhury S, Ghosh J, Pal S, Basu A, Bhattacharya A, Das A, Das D, Das-Gupta C. Protein folding by domain V of Escherichia coli 23S rRNA: specificity of RNA-protein interactions. J Bacteriol 2008; 190:3344-52; PMID:18310328; http://dx.doi.org/10.1128/JB.01800-07
27. Choi SI, Ryu K, Seong BL. RNA-mediated chaperone type for de novo protein folding. RNA Biol 2009; 6:21-4; PMID:19106620; http://dx.doi.org/10.4161/rna.6.1.7441
28. Choi SI, Han KS, Kim CW, Ryu KS, Kim BH, Kim KH, Kim SI, Kang TH, Shin HC, Lim KH, et al. Protein solubility and folding enhancement by interaction with RNA. PLoS One 2008; 3:e2677; http://dx.doi.org/10.1371/journal.pone.0002677
29. Choi SI, Lim KH, Seong BL. Chaperoning roles of macromolecules interacting with proteins in vivo. Int J Mol Sci 2011; 12:1979-90; PMID:21673934; http://dx.doi.org/10.3390/ijms12031979
30. Waldo GS, Standish BM, Berendzen J, Terwilliger TC. Rapid protein-folding assay using green fluorescent protein. Nat Biotechnol 1999; 17:691-5; PMID:10404163; http://dx.doi.org/10.1038/10904
31. Shaner NC, Patterson GH, Davidson MW. Advances in fluorescent protein technology. J Cell Sci 2007; 120:4247-60; PMID:18057027; http://dx.doi.org/10.1242/jcs.005801
32. Reiter NJ, Osterman A, Torres-Larios A, Swinger KK, Pan T, Mondragon A. Structure of a bacterial ribonuclease P holoenzyme in complex with tRNA. Nature 2010; 468:784-9; PMID:21076397; http://dx.doi.org/10.1038/nature09516
33. Tsai HY, Masquida B, Biswas R, Westhof E, Gopalan V. Molecular modeling of the three-dimensional structure of the bacterial RNase P holoenzyme. J Mol Biol 2003; 325:661-75; PMID:12507471; http://dx.doi.org/10.1016/S0022-2836(02)01267-6
34. Niranjanakumari S, Day-Storms JJ, Ahmed M, Hsieh J, Zahler NH, Venters RA, Fierke CA. Probing the architecture of the B. subtilis RNase P holoenzyme active site by cross-linking and affinity cleavage. RNA 2007; 13:521-35; PMID:17299131; http://dx.doi.org/10.1261/rna.308707
35. Buck AH, Kazantsev AV, Dalby AB, Pace NR. Structural perspective on the activation ofRNAse P RNA by protein. Nat StructMol Biol 2005; 12:958-64; PMID:16228004; http://dx.doi.org/10.1038/nsmb1004
36. Sharkady SM, Nolan JM. Bacterial ribonuclease P holoenzyme crosslinking analysis reveals protein interaction sites on the RNA subunit. Nucleic Acids Res 2001; 29:3848-56; PMID:11557817; http://dx.doi.org/10.1093/nar/29.18.3848
37. Gopalan V, Baxevanis AD, Landsman D, Altman S. Analysis of the functional role of conserved residues in the protein subunit of ribonuclease P from Escherichia coli. J Mol Biol 1997; 267:818-29; PMID:9135114; http://dx.doi.org/10.1006/jmbi.1997.0906
38. Jovanovic M, Sanchez R, Altman S, Gopalan V. Elucidation of structure-function relationships in the protein subunit of bacterial RNase P using a genetic complementation approach. Nucleic Acids Res 2002; 30:5065-73; PMID:12466529; http://dx.doi.org/10.1093/nar/gkf670
39. Shin JS, Kim KS, Ryu KS, Han K, Lee Y, Choi BS. Structural analysis of Escherichia coli C5 protein. Proteins 2011; 80(3):963-7.
40. Talbot SJ, Altman S. Kinetic and thermodynamic analysis of RNA-protein interactions in the RNase P holoenzyme from Escherichia coli. Biochemistry 1994; 33:1406-11; PMID:8312259; http://dx.doi.org/10.1021/bi00172a017
41. Kim Y, Lee Y. Novel function of C5 protein as a metabolic stabilizer of M1 RNA. FEBS Lett 2009; 583:419-24; PMID:19114042; http://dx.doi.org/10.1016/j.febslet.2008.12.040
42. Dobson CM. Protein misfolding, evolution and disease. Trends Biochem Sci 1999; 24:329-32; PMID:10470028; http://dx.doi.org/10.1016/S0968-0004(99)01445-0
43. Chiti F, Calamai M, Taddei N, Stefani M, Ramponi G, Dobson CM. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc Natl Acad Sci USA 2002; 99:16419-26; PMID:12374855; http://dx.doi.org/10.1073/pnas.212527999
44. Vendruscolo M, Knowles TP, Dobson CM. Protein solubility and protein homeostasis: a generic view of protein misfolding disorders. Cold Spring Harb Perspect Biol 2011; 3:a010454; PMID:21825020
45. Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 2007; 104:9741-6; PMID:17535913; http://dx.doi.org/10.1073/pnas.0702662104
46. Geoghegan JC, Valdes PA, Orem NR, Deleault NR, Williamson RA, Harris BT, Supattapone S. Selective incorporation of polyanionic molecules into hamster prions. J Biol Chem 2007; 282:36341-53; PMID:17940287; http://dx.doi.org/10.1074/jbc.M704447200
47. Silva JL, Lima LMTR, Foguel D, Cordeiro Y. Intriguing nucleic-acid-binding features of mammalian prion protein. Trends Biochem Sci 2008; 33:132-40; PMID:18243708; http://dx.doi.org/10.1016/j.tibs.2007.11.003
48. Tribouillard-Tanvier D, Dos Reis S, Gug F, Voisset C, Beringue V, Sabate R, Kikovska E, Talarek N, Bach S, Huang C, et al. Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs. PLos One 2008; 3:e2174
49. Pang YH, Kurella S, Voisset C, Samanta D, Banerjee D, Schabe A, Das Gupta C, Galons H, Blondel M, Sanyal S. The antiprion compound 6-aminophenanthridine inhibits the protein folding activity of the ribosome by direct competition. J Biol Chem 2013; 288:19081-9; PMID:23673663; http://dx.doi.org/10.1074/jbc.M113.466748
50. Uversky VN, Dunker AK. Understanding protein nonfolding. Biochim Biophys Acta 2010; 1804:1231-64; PMID:20117254; http://dx.doi.org/10.1016/j.bbapap.2010.01.017
51. Dunker AK, Gough J. Sequences and topology: intrinsic disorder in the evolving universe of protein structure. Curr Opin Struct Biol 2011; 21:379-81; PMID:21530236; http://dx.doi.org/10.1016/j.sbi.2011.04.002
52. Dyson HJ, Wright PE. Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Bio 2005; 6:197-208; http://dx.doi.org/10.1038/nrm1589
53. Wright PE, Dyson HJ. Linking folding and binding. Curr Opin Struc Biol 2009; 19:31-8; http://dx.doi.org/10.1016/j.sbi.2008.12.003
54. Xue B, Dunbrack RL, Williams RW, Dunker AK, Uversky VN. PONDR-FIT: A meta-predictor of intrinsically disordered amino acids. Biochim Biophys Acta 2010; 1804:996-1010; PMID:20100603; http://dx.doi.org/10.1016/j.bbapap.2010.01.011
55. Kozlowski LP, Bujnicki JM. MetaDisorder: a metaserver for the prediction of intrinsic disorder in proteins. BMC Bioinformatics 2012; 13(1):111; PMID:22624656; http://dx.doi.org/10.1186/1471-2105-13-111
56. Guo X, Campbell FE, Sun L, Christian EL, Anderson VE, Harris ME. RNA-dependent folding and stabilization of C5 protein during assembly of the E. coli RNase P holoenzyme. J Mol Biol 2006; 360:190-203; PMID:16750220; http://dx.doi.org/10.1016/j.jmb.2006.05.001
57. Fernandez A, Crespo A. Protein wrapping: a molecular marker for association, aggregation and drug design. Chem Soc Rev 2008; 37:2373-82; PMID:18949110; http://dx.doi.org/10.1039/b804150b
58. Kandror O, Busconi L, Sherman M, Goldberg AL. Rapid degradation of an abnormal protein in Escherichia coli involves the chaperones GroEL and GroES. J Biol Chem 1994; 269:23575-82; PMID:7916344
59. Kim YE, Hipp MS, Bracher A, Hayer-Hartl M, Hartl FU. Molecular chaperone functions in protein folding and proteostasis. Annu Rev Biochem Vol 82 2013; 82:323-55; PMID:23746257; http://dx.doi.org/10.1146/annurev-biochem-060208-092442
60. Li C, Schwabe JWR, Banayo E, Evans RM. Coexpression of nuclear receptor partners increases their solubility and biological activities. Proc Natl Acad Sci USA 1997; 94:2278-83.
61. Fribourg S, Romier C, Werten S, Gangloff YG, Poterszman A, Moras D. Dissecting the interaction network of multiprotein complexes by pairwise coexpression of subunits in E.coli. J Mol Biol 2001; 306:363-73; PMID:11237605; http://dx.doi.org/10.1006/jmbi.2000.4376
62. Mossakowska DE. Expression of nuclear hormone receptors in Escherichia coli. Curr Opin Biotech 1998; 9:502-5; PMID:9821279; http://dx.doi.org/10.1016/S0958-1669(98)80036-0
63. Uversky VN, Fink A. Protein misfolding, aggregation and conformational diseases: Part B: Molecular mechanisms of conformational diseases. Springer Science & Business Media, 2007; 6.
64. Choi SI, Kwon S, Son A, Jeong H, Kim KH, Seong BL. Protein folding in vivo revisited. Curr Protein Pept Sci 2013; 14:721-33; PMID:24384034; http://dx.doi.org/10.2174/138920371408131227170544
65. Oromendia AB, Amon A. Aneuploidy: implications for protein homeostasis and disease. Dis Model Mech 2014; 7:15-20; PMID:24396150; http://dx.doi.org/10.1242/dmm.013391
66. Kerner MJ, Naylor DJ, Ishihama Y, Maier T, Chang HC, Stines AP, Georgopoulos C, Frishman D, Hayer-Hartl M, Mann M, et al. Proteome-wide analysis of chaperonin-dependent protein folding in Escherichia coli. Cell 2005; 122:209-20; PMID:16051146; http://dx.doi.org/10.1016/j.cell.2005.05.028
67. Chapman E, Farr GW, Usaite R, Furtak K, Fenton WA, Chaudhuri TK, Hondorp ER, Matthews RG, Wolf SG, Yates JR, et al. Global aggregation of newly translated proteins in an Escherichia coli strain deficient of the chaperonin GroEL. Proc Natl Acad Sci USA 2006; 103:15800-5; PMID:17043235; http://dx.doi.org/10.1073/pnas.0607534103
68. Ullers RS, Luirink J, Harms N, Schwager F, Georgopoulos C, Genevaux P. SecB is a bona fide generalized chaperone in Escherichia coli. Proc Natl Acad Sci USA 2004; 101:7583-8; PMID:15128935; http://dx.doi.org/10.1073/pnas.0402398101
69. Niranjanakumari S, Stams T, Crary SM, Christianson DW, Fierke CA. Protein component of the ribozyme ribonuclease P alters substrate recognition by directly contacting precursor tRNA. Proc Natl Acad Sci USA 1998; 95:15212-7; PMID:9860948; http://dx.doi.org/10.1073/pnas.95.26.15212
70. Reich C, Olsen GJ, Pace B, Pace NR. Role of the protein moiety of ribonuclease P, a ribonucleoprotein enzyme. Science 1988; 239:178-81; PMID:3122322; http://dx.doi.org/10.1126/science.3122322
71. Guerrier-Takada C, Gardiner K, Marsh T, Pace N, Altman S. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 1983; 35:849-57; PMID:6197186; http://dx.doi.org/10.1016/0092-8674(83)90117-4
72. Lazcano A, Miller SL. The origin and early evolution of life: prebiotic chemistry, the pre-RNA world, and time. Cell 1996; 85:793-8; PMID:8681375; http://dx.doi.org/10.1016/S0092-8674(00)81263-5
73. Gesteland RF, Atkins JF. The RNA world : the nature of modern RNA suggests a prebiotic RNA world. Cold Spring Harbor, NY: Cold Spring Harbor Lab 1993; 271-302
74. Eddy SR. Non-coding RNA genes and the modern RNA world. Nat Rev Genet 2001; 2:919-29; PMID:11733745; http://dx.doi.org/10.1038/35103511